CD4 and T-cell non-Hodgkin lymphoma: Currently, there are no guidelines regarding the use of a particular modality to detect and monitor low level extra-GI disease dissemination in individuals with indolent small intestinal CD4+ T-cell lymphomas and data regarding systematic peripheral blood analysis by flow cytometry and PCR for TCRβ rearrangement are lacking.